PROVECTUS BIOPHARMACEUTICALS, INC. Other Comprehensive Income (Loss), before Tax
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) reported Other Comprehensive Income (Loss), before Tax of -$1.82 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeLossBeforeTax · last filed 2019-11-12
- PROVECTUS BIOPHARMACEUTICALS, INC. other comprehensive income (loss), before tax for the quarter ending 2019-09-30 was -$1.82M.
- PROVECTUS BIOPHARMACEUTICALS, INC. other comprehensive income (loss), before tax for the quarter ending 2019-06-30 was -$2.18M.
- PROVECTUS BIOPHARMACEUTICALS, INC. other comprehensive income (loss), before tax for the quarter ending 2019-03-31 was -$1.39M.
- PROVECTUS BIOPHARMACEUTICALS, INC. other comprehensive income (loss), before tax for the quarter ending 2018-09-30 was -$1.61M.
| Period end | Other Comprehensive Income (Loss), before Tax 3 month | Other Comprehensive Income (Loss), before Tax 6 month | Other Comprehensive Income (Loss), before Tax 9 month |
|---|---|---|---|
| 2019-09-30 | -$1.82M 10-Q · filed 2019-11-12 | -$4.00M derived: sum of 2 quarters · filed 2019-11-12 | -$5.39M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$2.18M 10-Q · filed 2019-08-08 | -$3.57M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | -$1.39M 10-Q · filed 2019-05-13 | ||
| 2018-09-30 | -$1.61M 10-Q · filed 2019-11-12 | -$3.07M derived: sum of 2 quarters · filed 2019-11-12 | -$5.96M 10-Q · filed 2019-11-12 |
| 2018-06-30 | -$1.46M 10-Q · filed 2019-08-08 | -$4.36M 10-Q · filed 2019-08-08 | |
| 2018-03-31 | -$2.90M 10-Q · filed 2019-05-13 |